Plenary Session

382 Afleveringen

1. 1.22 Elo-Pom-Dex, Immunotherapy Combos, Inherent Bias, and the FDA with Dr. Erick Turner

   Gepubliceerd: 13-11-2018
2. 1.21 Nab-Paclitaxel in CCA, OS of PALOMA-3, Transparency, and Dr. Talal Hilal's Advice for Trainees

   Gepubliceerd: 6-11-2018
3. 1.20 Precision Oncology: Some Benefit, Mostly Hype and Mentorship with Dr. Andrae Vandross

   Gepubliceerd: 30-10-2018
4. 1.19 BONUS! Introduction to Cancer Drug Policy

   Gepubliceerd: 26-10-2018
5. 1.18 IMpassion130 and Hot-Spotting with Dr. Brian Chan

   Gepubliceerd: 23-10-2018
6. 1.17 BONUS! Interpretation of Cancer Clinical Trials

   Gepubliceerd: 22-10-2018
7. 1.16 BONUS! Crowdsourcing Data Analysis and Medical Reversal: Why 40% of What We Do is Wrong

   Gepubliceerd: 17-10-2018
8. 1.15 Minimally Effective Treatments, CheckMate 331, and Dr. Adam Obley on Low-Value Healthcare

   Gepubliceerd: 16-10-2018
9. 1.14 BONUS! Immunotherapy in Desperation and the Pennington Lecture: Myths of Medicine and Marketing

   Gepubliceerd: 12-10-2018
10. 1.13 KEYNOTE-189, Dr. Talal Hilal on MRD, and Medical Education with Dr. Adam Cifu

    Gepubliceerd: 8-10-2018
11. 1.12 BONUS! Evidence-Based Medicine Has Been Hijacked in Oncology

    Gepubliceerd: 3-10-2018
12. 1.11 Peanut Gallery, Research Parasites, Appendectomies, HRQoL and PFS, Dr. Bishal Gyawali

    Gepubliceerd: 2-10-2018
13. 1.10 Criticism via Twitter, PACIFIC, PCI for CAD, and Dr. Rebecca Cooney of The Lancet

    Gepubliceerd: 25-9-2018
14. 1.09 Response Rate in Phase I trials, JACOB, and MI, Stroke, and Metastasis as Hard Endpoints

    Gepubliceerd: 20-9-2018
15. 1.08 Hyperprolific authors, NCCN with Jeff Wagner, and Dr. Renee Dversdal on Ultrasounds

    Gepubliceerd: 14-9-2018
16. 1.07 Adjuvant Sunitinib in RCC, future of EBM with Dr. John Mandrola

    Gepubliceerd: 11-9-2018
17. 1.06 RELEVANCE, Jenny Gill, and Dr. Catherine Livingston of the Oregon Health Authority

    Gepubliceerd: 7-9-2018
18. 1.05 Cost and Efficacy of Cancer Drugs, ECHELON-1, Dr. Derrick Tao, and EBM with Dr. Martha Gerrity

    Gepubliceerd: 5-9-2018
19. 1.04: Nutritional Epi, Lenvatinib, Nivo and Ipi for Melanoma, and Dr. Avi O'Glasser

    Gepubliceerd: 30-8-2018
20. 1.03: RWE, Right to Try, Talazoparib, Nivolumab, and Dr. Andrae Vandross

    Gepubliceerd: 21-8-2018